---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-036424"
form_type: "8-K"
ticker: "ADVB"
cik: "0001941029"
company_name: "Advanced Biomed Inc."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:27:35.223582+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Advanced Biomed CTO and director Steven I-Fang Cheng resigns; CFO Mingze Yin appointed to board

## Summary
- Steven I-Fang Cheng resigned as director and CTO effective March 25, 2026; no disagreement with company.
- Mingze Yin, CFO, appointed as director effective March 25, 2026.
- No family relationships or transactions requiring disclosure for Mr. Yin.

## SEC filing metadata
- accession: 0001213900-26-036424
- form_type: 8-K
- ticker: ADVB
- cik: 0001941029
- company_name: Advanced Biomed Inc.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1941029/000121390026036424/0001213900-26-036424-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1941029/000121390026036424/ea028408401-8k_advancedbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-036424
- JSON: https://secwatch.observer/filing/0001213900-26-036424.json
- Plain text: https://secwatch.observer/filing/0001213900-26-036424.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.